Maritta Salonoja
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maritta Salonoja has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
M. Salminen
1 shared publicationMarika Salminen
Institute of Clinical Medicine, Department of Family Medicine, University of Turku, Turku, Lemminkäisenkatu 1, FI-20014, Finland
1 shared publicationP. Aarnio
1 shared publicationPertti Aarnio
Department of Surgery, Satakunta Hospital District, Pori, Sairaalantie 3, FI-28500, Finland
1 shared publicationS.-L. Kivelä
1 shared publicationSirkka-Liisa Kivelä
Institute of Clinical Medicine, Department of Family Medicine, University of Turku, Turku, Lemminkäisenkatu 1, FI-20014, Finland 5 Satakunta Hospital District, Pori, Sairaalantie 3, FI-28500, Finland 6 Unit of Family Medicine, Turku University Hospital, Turku, Kiinamyllynkatu 4-8, FI-20520, Finland
1 shared publication
Latest Publications
- 1 January 2012
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 54 (1) , 160-167
Withdrawal of psychotropic drugs decreases the risk of falls requiring treatment
- 1 January 2012
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 54 (1) , 160-167
Withdrawal of psychotropic drugs decreases the risk of falls requiring treatment
- Open Access
- 20 January 2010
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 39 (3) , 313-319
One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons
Background: evidence about possibilities to help older persons to withdraw the long-term use of benzodiazepines (BZD) is scarce. Effective and practicable methods are needed. Objective: the study aimed to assess the persistence of one-time counselling by a geriatrician to reduce psychotropic drugs, especially BZD and related drugs (RD). Design: a prospective randomised controlled trial with a 12-month follow-up was conducted. Subjects: five hundred ninety-one community-dwelling people aged 65 or older participated in the study. Methods: instructions to withdraw, reduce or change psychotropic drugs were given to the intervention group. A 1-h lecture about these drugs and their adverse effects was given later on. No changes in the drug therapy were suggested for the controls. Results: the number of regular users of BZD and RD decreased by 35% (12/34) (odds ratios (OR) = 0.61, 95% confidence interval (95% CI) 0.44–0.86) in the intervention group while it increased by 4% (2/46) (OR = 1.05, 95% CI 0.81–1.36) in the controls (P = 0.012). No significant changes in the users of other types of psychotropics were found. Conclusion: one-time counselling of psychotropics and other fall-risk-increasing drugs by a geriatrician followed with a 1-h lecture about adverse effects of these drugs had positive effects in decreasing the number of regular users of BZD and RD, and these effects persisted for the total 12-month intervention period.
- 20 January 2010
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 39 (3) , 313-319
Open AccessOne-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons
Background: evidence about possibilities to help older persons to withdraw the long-term use of benzodiazepines (BZD) is scarce. Effective and practicable methods are needed. Objective: the study aimed to assess the persistence of one-time counselling by a geriatrician to reduce psychotropic drugs, especially BZD and related drugs (RD). Design: a prospective randomised controlled trial with a 12-month follow-up was conducted. Subjects: five hundred ninety-one community-dwelling people aged 65 or older participated in the study. Methods: instructions to withdraw, reduce or change psychotropic drugs were given to the intervention group. A 1-h lecture about these drugs and their adverse effects was given later on. No changes in the drug therapy were suggested for the controls. Results: the number of regular users of BZD and RD decreased by 35% (12/34) (odds ratios (OR) = 0.61, 95% confidence interval (95% CI) 0.44–0.86) in the intervention group while it increased by 4% (2/46) (OR = 1.05, 95% CI 0.81–1.36) in the controls (P = 0.012). No significant changes in the users of other types of psychotropics were found. Conclusion: one-time counselling of psychotropics and other fall-risk-increasing drugs by a geriatrician followed with a 1-h lecture about adverse effects of these drugs had positive effects in decreasing the number of regular users of BZD and RD, and these effects persisted for the total 12-month intervention period.